Burzynski Research Institute, Inc.
|
-0.01 USD
|
-3233.333%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
85.022%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
103.285%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-2437.313%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-959.19%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
105.714%
|
Qrons Inc.
|
-0.06 USD
|
-483.19%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-22566.667%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-491.304%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-3300.0%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
93.669%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
99.33%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-560.194%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
87.681%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-289.016%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-1334.599%
|
Mesoblast Limited
|
-0.09 USD
|
-281.594%
|
Marizyme, Inc.
|
-1.44 USD
|
76.389%
|
Genus plc
|
0.12 USD
|
383.333%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
85.408%
|
Pharming Group N.V.
|
-0.02 USD
|
-2011.801%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-48471.429%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
19.048%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-252.332%
|
ContraFect Corporation
|
-124.97 USD
|
99.728%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-709.524%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-2733.333%
|
IMV Inc.
|
-4.37 USD
|
92.22%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-860.452%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-339900.0%
|
ONE Bio Corp.
|
1.43 USD
|
123.776%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
41.379%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
-183.333%
|
Q BioMed Inc.
|
-0.08 USD
|
-335.339%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-383.642%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
-3.03%
|
Biomind Labs Inc.
|
-0.02 USD
|
-1998.765%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
99.956%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-4494.595%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-1608.543%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-14066.667%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-42400.0%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
-30.769%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-3763.636%
|
GB Sciences, Inc.
|
-0.00 USD
|
-8192.683%
|
Alpha Cognition Inc.
|
-0.15 USD
|
-126.667%
|
HST Global, Inc.
|
-0.03 USD
|
-1118.638%
|
CSL Limited
|
2.73 USD
|
112.454%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-578.643%
|
Halberd Corporation
|
-0.00 USD
|
-339900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-48471.429%
|
Agentix Corp.
|
-0.04 USD
|
-871.429%
|
Resverlogix Corp.
|
-0.01 USD
|
-2294.366%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-350.928%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
93.411%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
26253.846%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
1454.582%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-852.381%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-1600.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-530.798%
|
Zenith Capital Corp.
|
-0.07 USD
|
-386.409%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-648.899%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-5296.825%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
90.981%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-67900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-272.399%
|
Kadimastem Ltd
|
-0.78 USD
|
56.41%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
92.766%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
99.066%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
45.161%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-2757.143%
|
LadRx Corporation
|
0.68 USD
|
150.0%
|
Cell Source, Inc.
|
-0.17 USD
|
-100.0%
|
Regen BioPharma, Inc.
|
0.29 USD
|
217.241%
|
Regen BioPharma, Inc.
|
0.26 USD
|
230.769%
|
NovAccess Global Inc.
|
-0.23 USD
|
-47.826%
|
Affymax, Inc.
|
-0.39 USD
|
12.821%
|
Itoco Inc.
|
-0.01 USD
|
-4373.684%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-3300.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-13500.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-5971.429%
|
CytoDyn Inc.
|
-0.05 USD
|
-542.722%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-67900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-1431.532%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
99.779%
|
SYBLEU INC
|
-0.02 USD
|
-1842.857%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-2294.366%
|
International Stem Cell Corporation
|
-0.02 USD
|
-1973.171%
|
Bioxytran, Inc.
|
-0.03 USD
|
-965.831%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-339900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
95.745%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
71.186%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-900.0%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-5296.825%
|
Neutra Corp.
|
-0.00 USD
|
-339900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
99.639%
|
PureTech Health plc
|
-2.38 USD
|
85.714%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
59.036%
|
IXICO plc
|
-0.02 USD
|
-1293.443%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-498.592%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
74.815%
|
CSL Limited
|
5.47 USD
|
106.216%
|
Cellectis S.A.
|
-1.77 USD
|
80.791%
|